Ascendis Pharma A ASND
NASDAQ ASND
$238.90 +4.57 (+1.95%)
At close: Oct 21, 2026 · 4:00 PM EDT

Ascendis Pharma A (ASND) Total Current Liabilities (2012 - 2026)

Updated

Ascendis Pharma A's Total Current Liabilities was $540.37 million in the quarter ended Jun 30, 2026, down 48.9% from $1.06 billion a year earlier and down 59.0% from the prior quarter.

Analysis

Ascendis Pharma A (ASND) Total Current Liabilities (2012 - 2026) Analysis & Trends

As of Dec 31, 2025, Total Current Liabilities at Ascendis Pharma A came in at $1.21 billion, down 13.1% from the prior year.

  • Total Current Liabilities shows a five-year compound annual growth rate of 48.3% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Total Current Liabilities was $1.39 billion in the year ended Dec 31, 2024 (+74.6%), $796.69 million in the year ended Dec 31, 2023 (-8.5%), $870.98 million in the year ended Dec 31, 2022 (+278.2%) and $230.27 million in the year ended Dec 31, 2021 (+36.9%).
  • The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly Total Current Liabilities since the quarter ended Sep 30, 2023.
  • Compared with a year earlier, Total Current Liabilities was higher in six of the last eight quarters, with growth averaging 50.3%.
  • The best year-over-year quarter for Total Current Liabilities over five years was the quarter ended Jun 30, 2024 (growth of 336.0%); the worst was the quarter ended Jun 30, 2026 (a decline of 48.9%).
  • Per Business Quant data, ASND's Total Current Liabilities in the three quarters before the quarter ended Jun 30, 2026 was $1.32 billion (quarter ended Mar 31, 2026), $1.24 billion (quarter ended Dec 31, 2025) and $1.15 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 47.74 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 54.90 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 41.64 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 27.73 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 31.75 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 31.55 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 25.50 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 11.02 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 32.65 Bn
10 Ascendis Pharma A 14.48 Bn 10.74 Bn 362.22 Mn 531.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 531.00 Mn
Mar 31, 2026 1.29 Bn
Dec 31, 2025 1.26 Bn
Sep 30, 2025 1.16 Bn
Jun 30, 2025 1.10 Bn
Mar 31, 2025 958.47 Mn
Dec 31, 2024 944.74 Mn
Sep 30, 2024 936.54 Mn
Jun 30, 2024 907.79 Mn
Mar 31, 2024 862.45 Mn
Dec 31, 2023 815.18 Mn
Sep 30, 2023 224.72 Mn
Jun 30, 2023 208.96 Mn
Mar 31, 2023 216.31 Mn
Dec 31, 2022 182.59 Mn
Sep 30, 2022 140.40 Mn
Jun 30, 2022 120.27 Mn
Mar 31, 2022 106.43 Mn
Dec 31, 2021 113.65 Mn
Sep 30, 2021 134.72 Mn
API Access

Ascendis Pharma A Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=ASND&period=max&api_key=YOUR_API_KEY